Lack of early weight loss may indicate your dose needs adjustment, your GLP1R sensitivity variant requires higher dosing, or you may benefit from combination therapy like GLP-Squared (semaglutide plus tirzepatide)
Target HbA1c levels are typically 48 mmol/mol for most adults with type 2 diabetes at low risk of hypoglycaemia, or 53 mmol/mol for those on medications that can cause hypoglycaemia (such as sulphonylureas or insulin), with individualisation based on personal circumstances
However, everyone's body reacts differently, and studies dont always predict individual experiences
But every once in a while, a drug comes to the market that changes the landscape in the treatment of obesity
Rotate sites systematically (abdomen at least 2 inches from navel, thighs, upper arms) to avoid lipohypertrophy [8]
, , BPC 157 ex-vivo in vitro ,